systemic vasculitis & alpha-1 antitrypsin deficiency_ gema tirado-conde
DESCRIPTION
The systemic vasculitides are characterized by immune inflammation affecting blood vessels, which can lead to organ and tissue damage. One study showed that 8% of Wegener's granulomatosis (WG) patients had some degree of AATD (Alpha-1 antitrypsin deficiency). It's perhaps wise for all WG patients to be tested for AATD, especially if they're having bronchiectasis or similar conditions affecting breathing. Some rheumatologists order a lab test for AATD whenever a WG patient is diagnosed. This presentation, reviews this topic and hypothesize the role of replacement therapy in patients affected by both conditions.TRANSCRIPT
![Page 1: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/1.jpg)
![Page 2: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/2.jpg)
“Vasculitis”… You what????? AAT deficiency and natural history Going through the pathogenic link Relevant studies Conclusions
![Page 3: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/3.jpg)
““VasculitisVasculitis””… You what?????… You what????? AAT deficiency and natural history Going through the pathogenic link Relevant studies Conclusions
![Page 4: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/4.jpg)
Non specific termNon specific term
Systemic processSystemic process
Non specific manifestationsNon specific manifestations
Large & heterogeneous group of disorders Large & heterogeneous group of disorders characterized bycharacterized by
Inflammation of blood vesselsInflammation of blood vessels
![Page 5: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/5.jpg)
![Page 6: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/6.jpg)
![Page 7: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/7.jpg)
![Page 8: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/8.jpg)
“Vasculitis”… You what????? AAT deficiency and natural historyAAT deficiency and natural history Going through the pathogenic link Relevant studies Conclusions
![Page 9: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/9.jpg)
Genetic disorderGenetic disorderAATDAATD
Liver disease
Others:renal, vasculitis, etc
Lung disease
bronchiectasis
Airflow obstructionBronchial hiperresponssivenessasthmaCOPD
enphysema
![Page 10: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/10.jpg)
There is evidence of an association There is evidence of an association between AATD & systemic vasculitis.between AATD & systemic vasculitis.
AAT deficiency alone is not usually AAT deficiency alone is not usually enough to cause sysitemic vasculitis in enough to cause sysitemic vasculitis in the absence of other genetic and the absence of other genetic and environmental risk factors.environmental risk factors.
![Page 11: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/11.jpg)
“Vasculitis”… You what????? AAT deficiency and natural history Going through the pathogenic linkGoing through the pathogenic link Relevant studies Conclusions
![Page 12: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/12.jpg)
Neutrophil elastase is released during times of inflammation. This action is normally helpful and is balanced (neutralized) by the protein -1 antitrypsin produced in the liver.
• One cause of damage to any tissue is that elastase is produced by neutrophil but there is a genetically lack of -1 antitrypsin.
![Page 13: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/13.jpg)
S. Stolk. S. Stolk. Eur Respir Mon Eur Respir Mon 2006; 34: 139-1502006; 34: 139-150
macrophage
Airwways aneutrophils activation
Elastase
LTB4
Neutrophile recruitment Destruction area
![Page 14: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/14.jpg)
• There are normal regulatory There are normal regulatory mechanisms for control of secreted mechanisms for control of secreted neutrophil enzymes and control neutrophil enzymes and control pathways to limit the enzyme action by pathways to limit the enzyme action by anti-proteases.anti-proteases.
• These are highly important for These are highly important for neutralization of the enzymatic neutralization of the enzymatic activities of the neutrophil proteases.activities of the neutrophil proteases.
![Page 15: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/15.jpg)
Anti-proteaseshield prevents degradationof normal tissues
Then how can the neutrophilThen how can the neutrophilperform its normal functions?perform its normal functions?
![Page 16: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/16.jpg)
Subsequent to this attack
on anti-proteases, the neutrophil enzymesare free to damage the
bacterial targets, necrotic tissues, or in
pathological conditionnormal tissues.
![Page 17: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/17.jpg)
“Vasculitis”… You what????? AAT deficiency and natural history Going through the pathogenic link Relevant studiesRelevant studies Conclusions
![Page 18: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/18.jpg)
It’s been described that ANCA activate primed neurophiles and possibly induce accelerate apoptosis of tumor necrosis factor-primed neutrophils.
Actually, the titer of ANCA is correlated with the disease activity, and rises prior to clinical manifestations .
Savage COS et al. Lancet 1987; 1: 1389-93Savage COS et al. Lancet 1987; 1: 1389-93
![Page 19: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/19.jpg)
The main antigenic targets for ANCA are proteinase 3 (PR3) and myeloperoxidase (MPO).
Rao Nvet al. J Biol Chem 1991; 266: 9540-48Rao Nvet al. J Biol Chem 1991; 266: 9540-48
![Page 20: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/20.jpg)
Accordingly it is likely proteases play a role in pathogenesis of systemic vasculitis protease/antiprotease imbalance, which may be either :
genetically determined in AATD genetically determined in AATD pathological acquire inactivation. pathological acquire inactivation.
Rao Nvet al. J Biol Chem 1991; 266: 9540-48Rao Nvet al. J Biol Chem 1991; 266: 9540-48
![Page 21: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/21.jpg)
In some cases the serum is negative for ANCA, and it is apparent that other something than PR3-ANCA plays a role in releasing PR3.
![Page 22: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/22.jpg)
A subpopulation of AATD Pi*ZZ associated with ANCA(+) plus systemic vasculitis has been reported, but it was demonstrated there is no evidence that a Pi*ZZ patient carrying ANCA against PR3 or MPO has a greater risk of developing systemic vasculitis than a Pi*MM patient carrying ANCA
Audrain MAP et al. Nephrol Dial Transplant 2001; 16: 31-44Audrain MAP et al. Nephrol Dial Transplant 2001; 16: 31-44
![Page 23: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/23.jpg)
Although the vasculitis associated with AATD showed a more widespread and worse prognosis than vasculitis, in Pi*MM patients, there was no difference in age at onset or relapse tendency.
Audrain MAP et al. Nephrol Dial Transplant 2001; 16: 31-44Audrain MAP et al. Nephrol Dial Transplant 2001; 16: 31-44
![Page 24: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/24.jpg)
Previous reports have suggested an association between certain ANCA(+) vasculitis and AATD phenotypes .
Esnault VEsnault Vet al. Kidney Int et al. Kidney Int 1993; 43: 1329-13321993; 43: 1329-1332
![Page 25: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/25.jpg)
However, other small studies have given conflicting results, so it is unclear whether this is a consistent association and, if so, whether it is of significance as regards disease manifestations.
Elzouki AN et al. Elzouki AN et al. J Intern Med J Intern Med 1994; 236: 543-5481994; 236: 543-548 O'Donaghue D et al. In: Gross WL, ed. O'Donaghue D et al. In: Gross WL, ed. ANCA-Associated ANCA-Associated
Vasculitides: Immunological and Clinical Aspects. PVasculitides: Immunological and Clinical Aspects. Plenum Press, lenum Press, NY1993; 331-335NY1993; 331-335
![Page 26: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/26.jpg)
“Vasculitis”… You what????? AAT deficiency and natural history Going through the pathogenic link Relevant studies ConclusionsConclusions
![Page 27: Systemic vasculitis & Alpha-1 antitrypsin deficiency_ Gema Tirado-Conde](https://reader037.vdocuments.us/reader037/viewer/2022103115/556eb0add8b42aa32b8b4631/html5/thumbnails/27.jpg)
ANCAANCA neutrophilneutrophil activation activation
releasing proteases and ROS, releasing proteases and ROS,
which which may result may result in systemic in systemic vasculitis. vasculitis.
Since vasculitis didn’t result from the Since vasculitis didn’t result from the production of ANCA in some patients, production of ANCA in some patients, the evidence suggests… the evidence suggests…
AATD may be a serious genetic factor AATD may be a serious genetic factor exacerbating the vasculitis exacerbating the vasculitis regardless of the relation with ANCA.regardless of the relation with ANCA.